Use of Laparoscopic and Laparotomic J-Plasma Handpiece in Gynecological Malignancies: Results From A Pilot Study in A Tertiary Care Center
- PMID: 35837114
- PMCID: PMC9274254
- DOI: 10.3389/fonc.2022.868930
Use of Laparoscopic and Laparotomic J-Plasma Handpiece in Gynecological Malignancies: Results From A Pilot Study in A Tertiary Care Center
Abstract
Introduction: The J-Plasma has recently been introduced into the surgical community with different intrinsic characteristics aimed to further reduce the thermal effect and enhance precision when compared to standard radiofrequency. This study aimed to investigate the role of this new technology in different conditions of gynecological carcinomatosis characterized by the indication for regional peritonectomy and/or ablation, either in laparotomy (LPT) or in laparoscopy (LPS), in the context of a modern personalized approach to the surgical management of gynecological malignancies.
Material and methods: From January 2019 to April 2019, 12 patients were selected for this prospective pilot study at the Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome. In this single surgeon experience, the inclusion criteria were: histologically proven advanced ovarian/endometrial cancer, primary or interval debulking surgery, and intraoperative indication for regional peritonectomy. Six patients were treated by LPS (Group 1) and 6 by LPT (Group 2).
Results: In Group 1 the indication for debulking surgery was in 4 cases an interval debulking surgery and 2 advanced endometrial cancer. All patients in Group 2 underwent primary debulking surgery for advanced ovarian cancer. The whole cohort achieved a complete tumor excision after surgery. The median OT and median EBL were 195 min and 100 ml in Group 1, and 420 min and 500 ml in Group 2. The median hospital stay was 4 days in Group 1 and 13 days in Group 2, respectively. No intra and postoperative complications were registered within 60 days after surgery.
Conclusions: J-Plasma allows to approach delicate maneuvers on viscera, mesentery, and blood vessels with a high degree of safety and precision thanks to its limited vertical and lateral thermal spread, favoring the surgeon to push ever higher the cytoreduction/morbidity tradeoff. The use of J-Plasma in cytoreductive surgery could also increase the range of possible minimally invasive procedures, narrowing the technical distance with the open technique and thus contributing to designing a personalized surgical strategy for each patient in different scenarios of peritoneal carcinomatosis.
Keywords: J-Plasma; argon; cytoreductive surgery; endometrial cancer; laparoscopic surgery; laparoscopy; laparotomy; ovarian cancer.
Copyright © 2022 Gueli Alletti, Rosati, Capozzi, Pavone, Gioè, Cianci, Chiantera, Vizzielli, Scaglione, Fagotti and Scambia.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study.Am J Obstet Gynecol. 2016 Apr;214(4):503.e1-503.e6. doi: 10.1016/j.ajog.2015.10.922. Epub 2015 Oct 31. Am J Obstet Gynecol. 2016. PMID: 26529370 Clinical Trial.
-
Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes.J Minim Invasive Gynecol. 2015 Mar-Apr;22(3):428-32. doi: 10.1016/j.jmig.2014.11.008. Epub 2014 Nov 26. J Minim Invasive Gynecol. 2015. PMID: 25461683
-
Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.Ont Health Technol Assess Ser. 2010;10(27):1-118. Epub 2010 Dec 1. Ont Health Technol Assess Ser. 2010. PMID: 23074405 Free PMC article.
-
Role of minimally invasive surgery in ovarian cancer.J Minim Invasive Gynecol. 2013 Nov-Dec;20(6):754-65. doi: 10.1016/j.jmig.2013.04.027. J Minim Invasive Gynecol. 2013. PMID: 24183269 Review.
-
Novel Surgical Strategies in the Treatment of Gynecological Malignancies.Curr Treat Options Oncol. 2018 Nov 9;19(12):73. doi: 10.1007/s11864-018-0582-5. Curr Treat Options Oncol. 2018. PMID: 30411170 Review.
Cited by
-
Robot-assisted cholecystectomy with the new HUGO™ robotic-assisted system: first worldwide report with system description, docking settings, and video.Updates Surg. 2023 Oct;75(7):2039-2042. doi: 10.1007/s13304-023-01553-0. Epub 2023 Jul 10. Updates Surg. 2023. PMID: 37430097
-
Cutting Edge Microscopic Intraoperative Tissue Assessment for Guidance in Oncologic Surgery: A Systematic Review of the Role of Optical Coherence Tomography.Ann Surg Oncol. 2025 Mar;32(3):2191-2205. doi: 10.1245/s10434-024-16632-8. Epub 2024 Dec 8. Ann Surg Oncol. 2025. PMID: 39648239
-
Implementation and outcomes in benign gynecological surgery with HUGO™ RAS system 12 months initial experience.J Robot Surg. 2024 Sep 26;18(1):350. doi: 10.1007/s11701-024-02109-z. J Robot Surg. 2024. PMID: 39325064 Free PMC article.
-
Ultrasound-guided robotic surgical procedures: a systematic review.Surg Endosc. 2024 May;38(5):2359-2370. doi: 10.1007/s00464-024-10772-4. Epub 2024 Mar 21. Surg Endosc. 2024. PMID: 38512350 Free PMC article.
-
Emerging multi-port soft tissue robotic systems: a systematic review of clinical outcomes.J Robot Surg. 2024 Mar 30;18(1):145. doi: 10.1007/s11701-024-01887-w. J Robot Surg. 2024. PMID: 38554226 Free PMC article.
References
-
- Park DA, Lee DH, Kim SW, Lee SH. Comparative Safety and Effectiveness of Robot-Assisted Laparoscopic Hysterectomy Versus Conventional Laparoscopy and Laparotomy for Endometrial Cancer: A Systematic Review and Meta-Analysis. Eur J Surg Oncol (2016) 42(9):1303–14. doi: 10.1016/j.ejso.2016.06.400 - DOI - PubMed
-
- Merlier M, Kerbage Y, Pierache A, Ramdane N, Canlorbe G, Bolze PA, et al. . Impact on Prognosis of the Surgical Route, Laparoscopy or Laparotomy, for the Surgical Staging of Early Stage Ovarian Cancer-A Study From the FRANCOGYN Group. J Clin Med (2020) 9(11):3528. doi: 10.3390/jcm9113528 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous